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Abstract: 
Background: The scope of this consensus was to review the 
biological processes of soft tissue wound healing in the oral cavity 
and to histologically evaluate soft tissue healing in clinical and pre-
clinical models. 
Aims: To review the current knowledge regarding the biological 
processes of soft tissue wound healing at teeth, implants and on the 
edentulous ridge. Furthermore, to review soft tissue wound healing at 
these sites, when using barrier membranes, growth and 
differentiation factors and soft tissue substitutes. 
Collection of data: Searches of the literature with respect to 
recessions at teeth and soft tissue deficiencies at implants, 
augmentation of the area of keratinized tissue and soft tissue volume 
were conducted. The available evidence was collected, categorized 
and summarized. 
Fundamental principles of oral soft tissue wound healing: Oral 
mucosal and skin wound healing follow a similar pattern of the four 
phases of hemostasis, inflammation, proliferation, and 
maturation/matrix remodeling. The soft connective tissue determines 
the characteristics of the overlaying oral epithelium. Within 7-14 days, 
epithelial healing of surgical wounds at teeth is completed. Soft tissue 
	   3	  
healing following surgery at implants requires 6-8 weeks for 
maturation. The resulting tissue resembles scar tissue. 
Well-designed pre-clinical studies providing histological data have 
been reported describing soft tissue wound healing, when using 
barrier membranes, growth and differentiation factors and soft tissue 
substitutes. Few controlled clinical studies with low numbers of 
patients are available for some of the treatments reviewed at teeth. 
Whereas, histological new attachment has been demonstrated in pre-
clinical studies resulting from some of the treatments reviewed, 
human histological data commonly report a lack of new attachment 
but rather long junctional epithelial attachment and connective tissue 
adhesion. Regarding soft tissue healing at implants human data are 
very scarce. 
Conclusions: Oral soft tissue healing at teeth, implants and the 
edentulous ridge follows the same phases as skin wound healing. 
Histological studies in humans have not reported new attachment 
formation at teeth for the indications studied. Human histological data 
of soft tissue wound healing at implants is limited. 
Clinical Recommendations: The use of barriers membranes, 
growth and differentiation factors and soft tissue substitutes for the 
treatment of localized gingival/mucosal recessions, insufficient 
amount of keratinized tissue, and insufficient soft tissue volume is at 
a developing stage. 
Key words: periodontal/peri-implant wound healing, oral soft tissue, 
barrier membranes, growth and differentiation factors, scaffolds, soft 
tissue substitutes, pre-clinical studies, human histology 
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This consensus group evaluated in the first review the current 
evidence relating to the basic biological concepts of the oral wound 
healing response. As a part of the second review, a particular 
emphasis on early stage investigations of newly developed biological 
agents for periodontal soft tissue regeneration including barrier 
scaffolding matrices, biological agents (such as enamel matrix 
derivative, platelet-derived growth factor) and soft tissue substitutes 
was evaluated.  The second review focused on preclinical and clinical 
studies with the requirement of histological biopsy material of the 
wound repair process.  
  
The scope of Workshop Group 1, focused on two key areas: 1) soft 
tissue wound healing around teeth and dental implants (Sculean et 
al., 2014); and 2) soft tissue wound healing at teeth, dental implants 
and the edentulous ridge with barrier membranes, growth and 
differentiation factors and soft tissue substitutes (Vignoletti et al., 
2014). 
 
 
Soft tissue wound healing around teeth and dental implants 
(Sculean et al., 2014) 
 
The narrative review that was prepared by working group 1a focused 
on evaluating the wound healing concept in 3 key areas: Basic oral 
	   5	  
biological principles, soft tissue healing around teeth, and soft tissue 
repair around dental implants.  
 
Summary of key points of the review: 
 
1. Oral mucosal and skin wound healing follows a similar pattern of 
the four phases hemostasis, inflammation, proliferation and 
maturation/matrix remodeling. 
2. Infection control is important for undisturbed oral wound healing 
and is a prerequisite for the transition of the inflammatory to the 
proliferative phase. 
3. Granulation tissue derived from the periodontal ligament induces 
epithelial cells to form a keratinized masticatory gingiva. 
4. The soft connective tissue determines the characteristics of the 
overlaying oral epithelium. 
5. Epithelial healing around teeth following non-surgical and surgical 
periodontal therapy is completed after 7-14 days (Waerhaug, 1978, 
Novaes et al., 1969, Stahl et al., 1971). 
6. Functional stability between the denuded root and soft tissue is 
achieved approximately 14 days after surgery (Hiatt et al., 1968). 
7. The formation of the biologic width and maturation of the barrier 
function around transmucosal implants requires 6-8 weeks of 
healing (Berglundh et al., 2007, Tomasi et al., 2013, Schwarz et al., 
2013). 
8. The established peri-implant soft connective tissue resembles a 
scar tissue in composition, fiber orientation, and vasculature. 
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9. The peri-implant junctional epithelium may reach a greater final 
length under certain conditions such as implants placed into fresh 
extraction sockets versus conventional implant procedures in 
healed sites. 
 
Recommendations for Future Research 
 
Strategies for future research investigation to advance the field of oral 
wound healing around teeth and implants included the following 
target areas recommended by the expert review panel: 
 
-Need more information on the inductive influences of the connective 
tissue environment on tissue neogenesis.  Study at the cellular and 
matrix levels could be important in determining environmental cues.  
Cell: cell interactions (e.g., epithelial-mesenchymal influences) may 
instruct cell fate and determination. Identification of the cytokine, 
chemokine and intercellular signaling networks that are involved in 
the wound healing process may better inform on regenerative and 
reparative approaches.  The study of existing and newly discovered 
growth and differentiation factors may lead to new information on the 
repair and regeneration of oral tissues. 
 
Evidence gained from genetic models (i.e., transgenic and gene 
deletion) relevant to skin morphogenesis and regeneration may be 
instructive and translate to the oral wound healing situation.  More 
study is warranted to examine the oral wound healing response in the 
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face of the microbial challenge and local salivary molecules that may 
influence epigenetic changes of oral epithelia. 
 
-To identify host and immunological cellular and soluble factors that 
regulate the healing process during periodontal and peri-implant 
wound repair.  Determine what genetic biologic phenotypes may 
regulate an exacerbated healing responses depending on 
immunologic profiles.  It would also be valuable to study aging on oral 
soft tissue wound healing responses on cellular senescence and 
telomere length on stem cell progenitors contributing to the reparative 
process. 
 
-To investigate the mechanisms of connective tissue graft integration, 
revascularization and re-epithelialization as it relates to tissue 
remodeling (increases or decreases in tissue volume and quality) in 
different soft tissue biotype situations.  
 
-To identify the basic mechanisms and relevance of scar-like peri-
implant connective tissue and epithelial interface.  To determine the 
mechanisms of connective tissue adhesion to the implant material 
surface. The field would be advanced to better understand the 
biological consequences of implant/abutment biomaterial surface 
characteristics on the influence of biologic width formation.  The role 
of implant biomaterial surface characteristics on dental biofilm 
formation and proliferation should be considered. 
  
	   8	  
 
Soft tissue wound healing at teeth, dental implants and the 
edentulous ridge when using barrier membranes, growth and 
differentiation factors and soft tissue substitutes (Vignoletti et 
al., 2014) 
The narrative review that was prepared by working group 1b focused 
on evaluating the histological results of the application of scaffolds, 
cells and biological on soft tissue wound healing at teeth, dental 
implants and the edentulous ridge.  
Data were collected from pre-clinical experiments and from patient 
treatments reporting histological outcomes. Clinical studies, 
regardless of the evidence level provided, not reporting histological 
outcomes are not included in this review. As a consequence a large 
body of data derived from well-designed clinical studies are not 
included in this review. 
The level of evidence available for this review was mostly limited to 
well-designed pre-clinical studies and to clinical case series or case 
reports. Few controlled clinical studies with low numbers of patients 
were available for some of the treatments reviewed. The studies 
available were mostly of short duration not exceeding 6 months.  The 
studies available for evaluation were primarily associated with teeth.  
There was limited information available on soft tissue augmentation 
around implants.   
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Recessions at teeth and soft tissue deficiencies at dental implants 
Regarding recessions at teeth and soft tissue deficiencies at dental 
implants the following therapeutic approaches were evaluated: barrier 
membranes, growth and differentiation factors and soft tissue 
substitutes. 
Indications for the treatment of recessions at teeth and soft tissue 
deficiencies at dental implants include esthetic patient desires, root 
hypersensitivity and difficulty to perform plaque control. When 
evaluating the treatment approaches dealt with in this review, the 
coronally advanced flap (CAF) with and without a connective tissue 
graft (CTG) was used as a control. 
Available human histological data were often retrieved following 
treatment of hopeless teeth, very advanced or experimentally created 
defects. These extreme situations are far from the expected clinical 
use and, therefore, are suboptimal examples to assess the biological 
potential of these new technologies. 
Barrier membranes 
When barrier membranes were used at teeth in addition to CAF, 
increased amounts of new cementum, connective tissue attachment 
and reduced length of the junctional epithelium were observed. No 
significant differences were found related to these parameters 
between resorbable and non-resorbable membranes. 
The histological data revealed no adverse reactions resulting from the 
use of these materials. 
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The clinical differences between CAF with/without membranes were 
small in pre-clinical studies providing histology. 
Growth and differentiation factors 
The reason to introduce growth and differentiation factors is to induce 
new attachment formation in addition to the clinical coverage of the 
recession defect. 
Very little human histological data are available on the use of growth 
and differentiation factors. 
The factors reported in the review encompassed Enamel Matrix 
Derivative (EMD), Platelet Derived Growth Factor (PDGF) and 
Platelet Rich Plasma (PRP). 
The potential of EMD to promote new attachment has consistently 
been demonstrated in pre-clinical histological studies. Pre-clinical 
histological data is lacking comparing EMD to the standard of care. 
Histological data from humans, however, have failed to confirm new 
attachment formation. Favorable clinical data were reported in some 
of these human histological studies. 
In one histological study in humans PDGF (CAF+PDGF) exhibited 
new attachment formation in contrast to the control group 
(CAF+CTG). The clinical comparison in this study favored the 
controls regarding recession depth reduction and mean root 
coverage. 
In one pre-clinical histological study comparing CAF+CTG+PRP (test) 
versus the standard of care CAF+CTG, the test group showed more 
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new attachment formation than the control group. When comparing 
the two procedures, the residual recession was similar in this pre-
clinical study. No human histological datum is available.  
Soft tissue substitutes 
The reason to introduce soft tissue substitutes is to avoid the 
harvesting procedure and the concomitant morbidity associated with 
autogenous soft tissue grafts, which presently are the standard of 
care. 
The following materials have been histologically evaluated: acellular 
dermal matrix graft (ADMG), collagen matrices (CM), human 
fibroblast-derived dermal substitute (HF-DDS), and human skin 
equivalents (bilayered cell therapy: BCT). 
In three pre-clinical studies ADMG or CM have shown histological 
results regarding the tissue-tooth interface similar to the standard of 
care CAF+CTG and CAF alone, respectively. Human histological 
data have mostly shown epithelial attachment and connective tissue 
adhesion with an absence of adverse reactions. Successful recession 
coverage was reported in some of these human histological studies. 
In one pre-clinical study with dental implants the histological results 
for CAF+CM revealed a tissue implant interfaces similar to CAF+CTG 
or CAF alone consisting of epithelial attachment and connective 
tissue adhesion. The amount of coverage of the soft tissue 
deficiencies was similar for the three procedures, however both 
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experimental groups improved tissue thickness when compared with 
CAF alone. No human histological datum is available. 
Presently, there are no histological data available for HF-DDS and 
BCT. 
Augmentation of keratinized tissue 
The standard of care for increasing the zone of keratinized tissue is 
the apically positioned flap (APF) with an autogenous graft 
with/without epithelium, i.e. FGG or CTG. 
Soft tissue substitutes 
The following materials have been histologically evaluated: acellular 
dermal matrix graft (ADMG), collagen matrices (CM), and human skin 
equivalents (bilayered cell therapy: BCT). 
Generally speaking, there is little histological data assessing these 
materials in this indication. The histological pre-clinical and clinical 
data available demonstrate these materials to be well integrated into 
the host connective tissues without adverse reactions. 
In one pre-clinical study similar histological appearance was 
described for the increased zone of keratinized tissue comparing 
APF+CM with APF in edentulous areas of the ridge. The clinical 
results of this histological study have shown similar and large 
amounts of gain of keratinized tissue. 
Another pre-clinical study compared APF+CM to APF for increasing 
the zone of keratinized tissue. A tissue-tooth interface was found 
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consisting of epithelial attachment and connective tissue adhesion 
similar in both groups. The gain in keratinized tissue was similar but 
small in both groups. 
In one human study comparing APF+CM from a different source and 
APF+FGG, a good integration and keratinization of the CM was 
found. The clinical results, however, reported smaller amounts of gain 
of keratinized tissue compared to the controls. 
ADMG was tested in a pre-clinical and two human studies for 
augmentation of keratinized tissue at teeth in combination with APF. 
Histology revealed good tissue integration and a small gain of 
keratinized tissue associated with the ADMG. 
In one clinical case aiming at increasing the zone of keratinized tissue 
at an implant site retrieval of a histological sample revealed 
inflammation and degeneration of the ADMG. 
BCT was tested in one human study together with an APF against 
APF+FGG. Histologically good integration and keratinization were 
found for both groups investigated. The FFG group revealed more 
gain of keratinized tissue. 
Augmentation of insufficient soft tissue volume 
The standard of care for increasing the volume of the soft tissue is 
the transplantation of an autogenous graft with/without epithelium, i.e. 
CTG or FGG. 
Soft tissue substitutes 
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A modified xenogenic collagen matrix (mCM) has been histologically 
evaluated for soft tissue augmentation and compared to the CTG in 
one pre-clinical study. The histological analysis demonstrated similar 
integration into the surrounding tissues. Concomitant clinical 
measurements of volume gain demonstrated results similar to the 
one obtained with the CTG. 
 
Implications for Future Research 
• Since histological assessments may not be reliable to estimate 
the increase/ change in soft tissue thickness, these studies 
should consider different methodologies/ technologies (e.g. 3D 
digital imaging analysis). 
• There is a need to properly define valid and reproducible 
preclinical models for the assessment of soft tissue 
regeneration procedures around teeth and implants. 
• Future preclinical studies should be adequately powered and 
consider primary outcomes that are relevant for clinical 
situations (e.g., use of non-histologic surrogate measures that 
can be measured clinically). 
• Success criteria associated with soft tissue augmentation 
around teeth and implants may differ and need to be defined 
separately. 
• Future studies should elaborate on potential indications and the 
clinical relevance of new soft tissue augmentation procedures 
and long-term effects. 
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• Patient-centered/ reported outcomes should be an integral part 
of the evaluation of new biotechnologies when compared with 
current standard procedures. 
• Safety analyses and reporting should, in addition to local (e.g. 
clinical and histological) signs of potential immunologic 
responses, also consider assessment of antibody levels formed 
in response to xenogenic- or allogenic-derived biomaterials. 
• Health economics should be considered in the assessment of 
interventions and the introduction of new technologies. 
 
Clinical Consequences 
• The use of barriers membranes, growth and differentiation 
factors and soft tissue substitutes for the treatment of localized 
gingival/mucosal recessions, insufficient amount of keratinized 
tissue, and insufficient soft tissue volume is at a developing 
stage. 
• The conduct of preclinical studies is advantageous in order to 
preselect potential candidate materials that can be safely used 
in early stage clinical trials. 
• There continues to be a need for well designed, randomized, 
parallel-arm controlled clinical trials to further evaluate the 
efficacy of new technologies for the treatment of localized 
gingival/mucosal recessions, limited zones of keratinized tissue, 
and insufficient soft tissue volume. The potential influence of 
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relevant confounding clinical factors (e.g., flap design, suturing 
techniques) should also be carefully addressed. 	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